Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shamaila Munir Ahmad

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Cancer Immunology, Immunotherapy : CII|January 4, 2016
PD-L1-specific T cellsShamaila Munir Ahmad, Troels Holz Borch, Morten Hansen, et al.
Cellular & Molecular Immunology|May 12, 2019
Peripheral memory T cells specific for Arginase-1Evelina Martinenaite, Shamaila Munir Ahmad, Inge Marie Svane, et al.
Signal Transduction and Targeted Therapy|June 23, 2026
Engineering T cells with a novel PD-L1-specific TCR targeting immune and cancer cellsThomas Landkildehus Lisle, Emilie Bülow Jacobsen, Shamaila Munir Ahmad, et al.
Stem Cell Investigation|January 13, 2017
Peptide vaccination against multiple myeloma using peptides derived from anti-apoptotic proteins: a phase I trialNicolai Grønne Jørgensen, Shamaila Munir Ahmad, Niels Abildgaard, et al.
Cancer Immunology, Immunotherapy : CII|November 7, 2019
Arginase-1-based vaccination against the tumor microenvironment: the identification of an optimal T-cell epitopeEvelina Martinenaite, Shamaila Munir Ahmad, Simone Kloch Bendtsen, et al.
Oncoimmunology|May 12, 2015
Spontaneous presence of FOXO3-specific T cells in cancer patientsStine Kiaer Larsen, Shamaila Munir Ahmad, Manja Idorn, et al.
Oncoimmunology|September 14, 2016
PD-L1 peptide co-stimulation increases immunogenicity of a dendritic cell-based cancer vaccineShamaila Munir Ahmad, Evelina Martinenaite, Morten Hansen, et al.
Signal Transduction and Targeted Therapy|March 24, 2026
Rationale for multi-epitope TGFβ vaccination in pancreatic cancer: evidence from immunologic and clinical correlatesJosephine Hallundbæk Ruders, Shamaila Munir Ahmad, Rasmus Erik Johansson Mortensen, et al.
Oncoimmunology|December 22, 2016
CCL22-specific T Cells: Modulating the immunosuppressive tumor microenvironmentEvelina Martinenaite, Shamaila Munir Ahmad, Morten Hansen, et al.
Oncoimmunology|February 6, 2018
Frequent adaptive immune responses against arginase-1Evelina Martinenaite, Rasmus Erik Johansson Mortensen, Morten Hansen, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Cancer Immunology, Immunotherapy : CII|January 4, 2016
PD-L1-specific T cellsShamaila Munir Ahmad, Troels Holz Borch, Morten Hansen, et al.
Cellular & Molecular Immunology|May 12, 2019
Peripheral memory T cells specific for Arginase-1Evelina Martinenaite, Shamaila Munir Ahmad, Inge Marie Svane, et al.
Signal Transduction and Targeted Therapy|June 23, 2026
Engineering T cells with a novel PD-L1-specific TCR targeting immune and cancer cellsThomas Landkildehus Lisle, Emilie Bülow Jacobsen, Shamaila Munir Ahmad, et al.
Stem Cell Investigation|January 13, 2017
Peptide vaccination against multiple myeloma using peptides derived from anti-apoptotic proteins: a phase I trialNicolai Grønne Jørgensen, Shamaila Munir Ahmad, Niels Abildgaard, et al.
Cancer Immunology, Immunotherapy : CII|November 7, 2019
Arginase-1-based vaccination against the tumor microenvironment: the identification of an optimal T-cell epitopeEvelina Martinenaite, Shamaila Munir Ahmad, Simone Kloch Bendtsen, et al.
Oncoimmunology|May 12, 2015
Spontaneous presence of FOXO3-specific T cells in cancer patientsStine Kiaer Larsen, Shamaila Munir Ahmad, Manja Idorn, et al.
Oncoimmunology|September 14, 2016
PD-L1 peptide co-stimulation increases immunogenicity of a dendritic cell-based cancer vaccineShamaila Munir Ahmad, Evelina Martinenaite, Morten Hansen, et al.
Signal Transduction and Targeted Therapy|March 24, 2026
Rationale for multi-epitope TGFβ vaccination in pancreatic cancer: evidence from immunologic and clinical correlatesJosephine Hallundbæk Ruders, Shamaila Munir Ahmad, Rasmus Erik Johansson Mortensen, et al.
Oncoimmunology|December 22, 2016
CCL22-specific T Cells: Modulating the immunosuppressive tumor microenvironmentEvelina Martinenaite, Shamaila Munir Ahmad, Morten Hansen, et al.
Oncoimmunology|February 6, 2018
Frequent adaptive immune responses against arginase-1Evelina Martinenaite, Rasmus Erik Johansson Mortensen, Morten Hansen, et al.
Pageof 3